HLF - Herbalife Nutrition Ltd.

NYSE - Nasdaq Real Time Price. Currency in USD
-0.93 (-2.11%)
As of 2:47PM EDT. Market open.
Stock chart is not supported by your current browser
Previous Close43.90
Bid43.00 x 1000
Ask43.01 x 1200
Day's Range42.53 - 43.86
52 Week Range41.20 - 61.77
Avg. Volume2,048,820
Market Cap6.066B
Beta (3Y Monthly)0.43
PE Ratio (TTM)20.50
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2014-02-28
1y Target EstN/A
Trade prices are not sourced from all markets
  • Markityesterday

    See what the IHS Markit Score report has to say about Herbalife Nutrition Ltd.

    Herbalife Nutrition Ltd NYSE:HLFView full report here! Summary * Bearish sentiment is low and declining * Economic output in this company's sector is contracting Bearish sentimentShort interest | PositiveShort interest is low for HLF with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on June 14. Money flowETF/Index ownership | NeutralETF activity is neutral. ETFs that hold HLF had net inflows of $2.19 billion over the last one-month. While these are not among the highest inflows of the last year, the rate of inflow is increasing. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers’ Index (PMI) data, output in the Consumer Servicesis falling. The rate of decline is significant relative to the trend shown over the past year, and is accelerating. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to score@ihsmarkit.com.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.

  • Here’s What Hedge Funds Think About Herbalife Nutrition Ltd. (HLF)
    Insider Monkey9 days ago

    Here’s What Hedge Funds Think About Herbalife Nutrition Ltd. (HLF)

    As we already know from media reports and hedge fund investor letters, many hedge funds lost money in fourth quarter, blaming macroeconomic conditions and unpredictable events that hit several sectors, with technology among them. Nevertheless, most investors decided to stick to their bullish theses and recouped their losses by the end of the first quarter. […]

  • Net Worth of Cristiano Ronaldo
    Investopedia19 days ago

    Net Worth of Cristiano Ronaldo

    Find out Cristiano Ronaldo's net worth and how he became one of the richest athletes in the world.

  • Is Herbalife Nutrition Ltd.’s (NYSE:HLF) 47% ROCE Any Good?
    Simply Wall St.27 days ago

    Is Herbalife Nutrition Ltd.’s (NYSE:HLF) 47% ROCE Any Good?

    Today we'll evaluate Herbalife Nutrition Ltd. (NYSE:HLF) to determine whether it could have potential as an investment...

  • Motley Foollast month

    How Do Multilevel Marketing Companies Make Their Money?

    It's often not through selling to the public.

  • Motley Foollast month

    The Trouble With Multilevel Marketing Schemes

    Bob Everyman listened to this podcast, and now he makes $7,000 a month (aka, why MLMs are a waste of time and money).

  • Thomson Reuters StreetEventslast month

    Edited Transcript of HLF earnings conference call or presentation 2-May-19 9:30pm GMT

    Q1 2019 Herbalife Nutrition Ltd Earnings Call

  • Herbalife (HLF) Q1 Earnings Miss Estimates, Stock Down 4%
    Zacks2 months ago

    Herbalife (HLF) Q1 Earnings Miss Estimates, Stock Down 4%

    Herbalife Nutrition (HLF) posts dismal results in first-quarter 2019. Also, the company provides view for the second quarter and lowers its guidance for 2019.

  • There Is Good News in Herbalife’s Post-Earnings Action
    InvestorPlace2 months ago

    There Is Good News in Herbalife’s Post-Earnings Action

    Herbalife (NYSE:HLF) is no stranger to headlines. We all remember the wild moves on the verbal jabs between two titans of investing. Bill Ackman openly shorted the stock and Carl Icahn fiercely defended it. The fight went on for months but has since faded away.Source: Aybek Erkinov via FlickrToday, HLF stock is moving on a different kind of headline. Last night they reported earnings and investors hated the results. They missed both on the top and bottom lines. Also they made no headway against last year's numbers so there was little to celebrate.These day traders are quick to sell stock on even good reports, so they will sure sell the bad one. To make matters worse, management guided full-year numbers that are lower than anticipated. That alone is reason enough to crater the Herbalife stock. Frankly I am surprised that the drop isn't bigger than this 4% dip on headline. Perhaps it is because the stock came into the earnings down 10% already when the S&P 500 is up 16% year to date.InvestorPlace - Stock Market News, Stock Advice & Trading Tips What's Next for HLF StockSo is this a good time to catch the falling knife? Unfortunately there isn't one definitive answer because it all depends on the investor time frame and thesis.Fundamentally, HLF is not cheap. It sells at a 26 trailing price-to-earnings ratio, which is almost twice that of Apple (NASDAQ:AAPL), for example. This could be symptomatic of the industry because it is in line with Nu Skin (NYSE:NUS) valuation. * 10 Cheap Stocks to Buy in May, But Don't Go Away Nevertheless, if there is trouble on Wall Street, I'd bet that there is much more froth to come out of the HLF stock. This is not a knock against the company or its prospects. This is more to do with assessing the downside risk should the selling persist.This week, we have seen more negative rhetoric calling for marketwide tops. Although I disagree with them, I have to respect the possibility that they are correct. This is proper risk management -- regardless of my own opinion, I have to consider all scenarios in play.Technically, HLF stock has a ton of trouble looming just below the surface. But luckily, so far the bulls have succeeded in defending the $50 level. In fact while the S&P 500 fell into its lows in December, Herbalife climbed higher from its bottom two months earlier. That is a sign of solid support.The bad news is, that makes the line very important to hold. If for any reason the bulls lose it, then they trigger a bearish pattern to target $47.50 first then $42 or lower. This again is not a forecast, but it is one of the possible scenarios at hand.Last night's earnings report did not hold much good news, so it is hard to gauge if the weakness in their business will persist. Hopefully management guided lower to a number that they can actually beat, so they can over-deliver in three months.The macroeconomic environment still favors the bullish thesis, but there are a lot of geopolitical threats that loom -- mainly from the tariff wars. Sentiment, while much improved from last year, is still delicate. The bulls have one foot out the door at all times while we are still close to an all-time high.The currency markets have been wild of late due to manipulation from the global central banks. This no doubt played a role in hurting Herbalife's business. Regardless, the sales line needs to show growth for the company to continue to command its premium on Wall Street. Otherwise investors will reconsider their valuations for it.This is a bottom that should hold even after the bad news of the quarter. So if I am already long I can hold out a few more ticks with proper stop losses. But if I want to start a new position now, it should be a fundamental one, meaning I'd be ready to hold it for the long term in case the price continues lower.Otherwise, I'd classify it as a tactical trade and I'd need to be nimble with my stop orders. Else I'd risk turning a trade into an investment.Nicolas Chahine is the managing director of SellSpreads.com. As of this writing, he did not hold a position in any of the aforementioned securities. You can follow him as @racernic on Twitter and Stocktwits. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 10 Best Stocks to Buy for May * 7 Stocks Worth Buying When They're Down * 7 of the Best ETFs to Buy for a Slowing Economy Compare Brokers The post There Is Good News in Herbalife's Post-Earnings Action appeared first on InvestorPlace.

  • Herbalife Nutrition Ltd. (HLF) Q1 2019 Earnings Call Transcript
    Motley Fool2 months ago

    Herbalife Nutrition Ltd. (HLF) Q1 2019 Earnings Call Transcript

    HLF earnings call for the period ending March 31, 2019.

  • Benzinga2 months ago

    Q1 Earnings Preview For Herbalife

    On Thursday, May 2, Herbalife (NYSE: HLF ) will release its latest earnings report. Benzinga's report can help you figure out the ins and outs of the earnings release. Earnings and Revenue Analysts covering ...

  • Bill Ackman Is Making a Strong Comeback in 2019
    Market Realist2 months ago

    Bill Ackman Is Making a Strong Comeback in 2019

    Bill Ackman Thanks Warren Buffett for His Fund’s Comeback in 2019Bill Ackman is making a strong comeback in 2019Bill Ackman, Pershing Square’s founder and CEO, spoke at a money manager conference in New York on April 16. This year is turning out

  • 3 Personal Products Stocks to Revitalize Your Portfolio
    InvestorPlace2 months ago

    3 Personal Products Stocks to Revitalize Your Portfolio

    In a trading world where investors seek the latest technology or the newest trend, personal products stocks tend to receive less attention. As an older industry which mostly produces commoditized products, investment interest in this sector tends to revolve around preserving existing wealth or generating dividend income. * 7 Stocks to Buy for Spring Season Growth Despite the perception, these firms may receive more attention as they innovate on product development or marketing. Also, a growing presence in emerging markets has also bolstered these consumer staples stocks. Although many personal products stocks could bring opportunity, these three appear especially well-positioned to profit investors:InvestorPlace - Stock Market News, Stock Advice & Trading Tips Herbalife (HLF)Source: Aybek Erkinov via FlickrOne can argue that Herbalife (NYSE:HLF) has become better-known for hedge fund interest than what the firm produces. However, with Carl Icahn finally winning on his long bet against short-seller Bill Ackman, traders can evaluate HLF stock on sales and profit growth.The Cayman Islands-based nutrition company makes products for nutrition, energy, sports and fitness. However, its weight management segment drives more than 50% of its revenue. Though weight management encompasses multiple products, the division centers on its original product, protein shake. This Formula 1 shake is a soy-based product marketed as a "meal replacement." The company sells its product directly to the public via multi-level marketing.Unlike most personal products stocks, HLF acts as more of a growth equity. While it does not pay a dividend, it has begun to post improving growth numbers. After stagnating in the middle of the decade, revenues again started to increase in 2018. Revenue growth seems to have returned as Wall Street predicts a 6.1% increase for this year and 6.6% growth in 2020.As a result, profit increases have returned to double-digit levels, with earnings rising by 10.1% this year. This takes the forward P/E ratio to just under 14.4.HLF stock can rise, the question is how much? Herbalife currently trades at almost $53 per share. The one point of concern is it appears to have become stuck in a range. Since last August, it has twice pulled back from the low $60s per share level. I think the improving profit outlook can at least take it back to that level. However, it will need to break out of this range to sustain a longer-term upward trend. Nu Skin Enterprises (NUS)Nu Skin Enterprises (NYSE:NUS) is a multilevel marketing company who produces and sells both dietary supplements and personal care products. They market under the Nu Skin and Pharmanex brand names.The Provo, Utah-based firm operates in about 50 markets worldwide. According to the company's 10-K, they derive about 88% of their revenue from outside the U.S. Its largest market, mainland China, accounts for around 33% of that revenue.Like most personal products stocks, NUS stock pays a dividend. The current annual payout of $1.48 per share has increased every year since 2001. For new shareholders, it also yields around 2.9%, well above S&P 500 averages.A falling stock price may explain the relatively high yield. Over the last six months, the equity has lost over 40% of its value. This decline stems from its significant presence in China and investigations. Chinese authorities allege firms such as Nu Skin engaged in the unlawful promotion of health and wellness products. In early January, China instituted a 100-day ban on business meetings.The uncertainty surrounding this probe has hammered NUS stock. Consequently, investors may have a buying opportunity. NUS stock now trades at a forward P/E ratio of 11.6. Equities forecasted to increase profits by an average of 11.35% per year over the next five years rarely trade at such a low multiple. * 10 S&P 500 Stocks to Weather the Earnings Storm The tenuous situation in China adds to the risk of NUS stock. For this reason, it might make sense to wait or to buy only for the dividend. However, I think once the current crackdown ends, investors will hold a low-priced, high-growth stock with a generous payout. Unilever (UL, UN)Investors often confuse the stocks of London-based Unilever PLC (NYSE:UL) and Unilever N.V. (NYSE:UN) based in the Netherlands. Despite the legal separation, both are Unilever. It maintains this dual headquarters arrangement and two tickers for a variety of reasons. Still, while UN faces higher dividend taxes, UL and UN remain almost identical for purposes of U.S. traders.Unilever owns a wide variety of consumer brands including Ben & Jerry's Ice Cream, Lipton Tea, Dove soap, and Axe skin products. In 2018, it derived about 60% of its revenue from personal products. The remainder came from packaged food-type products. It has undergone cost-cutting initiatives over the last few years and has aggressively moved into emerging markets.Over the long-term, UL and UN stock have generally risen, though it has stagnated over the last year. As of this writing, UN trades at about $57.50 per share, near its 52-week high. Still, both tickers support a forward P/E of about 20. Also, analysts expect an average 9.3% per year increase in profits over the next five years.For this reason, most of the benefit of owning UL and UN stock comes from the dividend. Since the company pays in pounds and euro, payouts may fluctuate. However, the stocks currently yield about 3.05%. Dividends also rise annually, at least when measured in the currency of their respective countries.Unilever may trade at a somewhat higher multiple compared to other personal products stocks. However, with its growing presence in emerging markets, both UN and UL stock can become a profitable growth and income play.As of this writing, Will Healy did not hold a position in any of the aforementioned stocks. You can follow Will on Twitter at @HealyWriting. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Stocks to Buy for Spring Season Growth * This Is How You Beat Back a Bear Market * 7 Dental Stocks to Buy That Will Make You Smile Compare Brokers The post 3 Personal Products Stocks to Revitalize Your Portfolio appeared first on InvestorPlace.

  • The Best Way to Play Diet Stocks for Profits Right Now
    InvestorPlace2 months ago

    The Best Way to Play Diet Stocks for Profits Right Now

    In many respects, Weight Watchers (NYSE:WTW) and Herbalife (NYSE:HLF) could be said to be two peas in a pod. But with one planting the seeds to sprout future share growth on the price chart and the other looking ready for harvest, it's time for a well-timed pairs trade to capture a shrinking spread in WTW stock and shares of HLF.Source: Mike Mozart via FlickrWTW stock and Herbalife have a lot in common. Both are positioned to cash in on the global obsession with slimming down through a combination of products, programs and better food choices aimed at achieving a healthier you. But it can still be a tough sell.While both Weight Watchers and HLF have proven successful ventures over the years, maintaining consistent success at the customer level is more challenging for a myriad of reasons. From retaining the customers they're supposed to liberate, old habits dying hard in today's fast food, on-the-go way of life and relentless competition always hawking the newest genie in the bottle, there's going to be cyclical ups and downs for both names within this secular growth industry.InvestorPlace - Stock Market News, Stock Advice & Trading TipsBearing that in mind, it now appears to be an opportune time to buy into an out-of-favor and slimmed down WTW stock and pair up the entry with a short in shares of Herbalife in order to capture a shrinking price spread. Diet Stock Pairs Trade Long: WTW StockWTW stock may as well have been called 'SlimFast' over the past several months. After enjoying a massive run of nearly 800% from 2017 into 2018's first half, Weight Watchers has quickly shed those gains with shares off more than 80% since last June. * 10 Dividend Growth Stocks You Can't Miss There are a ton of excuses for the dive in share price. Most recently, there was a below-the-market price target reduction from JPMorgan, which ironically enough kept its rating on Weight Watchers stock at underweight.But a larger reason for the massive shred in WTW has been the fact that fewer customers have been staying onboard and signing up for Weight Watchers. Growth has been slipping for three consecutive quarters, while subscribers peaked at 4.6 million in Q1 of 2018. Entering 2019, that number now stands at 3.9 million. Click to EnlargeThe good news is as bad as it sounds and looks today, it's not likely to be permanent.The better news? Who knows? Maybe Monday's relative price relief prompted by Morgan Stanley, which noted it sees subscriber growth making a comeback, is a sign a new and more positive cycle is beginning?With WTW stock having been through an extreme weight loss program in its own right and Wall Street still mostly pooh-poohing shares, it's time to buy Weight Watchers as one-half of a pairs trade when few others are willing to gobble it up. Diet Stock Pairs Trade Short: HLF StockMost investors that follow the market are aware of Bill Ackman's infamous Herbalife capitulation in early 2018. It turns out he saved his investors some money during the interim. But he may soon be kicking himself for the exit -- though maybe not for the same reasons behind the short position.By late February of this year, Herbalife has seemingly put much of its troubles behind it and its earnings confessional supports a company that continues to grow. But Herbalife may have set itself up as a short prone to crumbling under its own weight by merely meeting Street forecasts for its fourth quarter and issuing below-view guidance for 2019. * 7 Stocks to Buy for Spring Season Growth After HLF stock's massive rally, a larger downdraft in HLF stock makes sense, especially in a market known for its ability to wear out and fool the crowd. Click to EnlargeTechnically, my bearish thesis does appear to be in the beginning stages of playing out after shares hit all-time-highs back in early February. Following an uneventful earnings reaction highlighted in the weekly chart, HLF stock has broken below trendline support formed during a sloping triple top pattern.Now shares of Herbalife are signaling a continuation to the downside after a narrow break of a tight consolidation pattern formed the past couple weeks. And as the other half of a pairs trade looking to trim some fat from HLF stock and shrink the spread with WTW stock, Herbalife looks like a great short.Disclosure: Investment accounts under Christopher Tyler's management do not currently own positions in any securities mentioned in this article. The information offered is based upon Christopher Tyler's observations and strictly intended for educational purposes only; the use of which is the responsibility of the individual. For additional options-based strategies, related musings or to ask a question, you can find and follow Chris on Twitter @Options_CAT and StockTwits. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * 7 Internet Stocks to Watch * 7 AI Stocks to Watch with Strong Long-Term Narratives * 10 Dow Jones Stocks Holding the Blue Chip Index Back Compare Brokers The post The Best Way to Play Diet Stocks for Profits Right Now appeared first on InvestorPlace.

  • Does Herbalife Nutrition's (NYSE:HLF) Share Price Gain of 92% Match Its Business Performance?
    Simply Wall St.2 months ago

    Does Herbalife Nutrition's (NYSE:HLF) Share Price Gain of 92% Match Its Business Performance?

    When we invest, we're generally looking for stocks that outperform the market average. Buying under-rated businesses is one path to excess returns. For example, long term Herbalife Nutrition Ltd. (NYSE:HLF) shareholders...

  • Dozens of companies leaked sensitive data thanks to misconfigured Box accounts
    TechCrunch3 months ago

    Dozens of companies leaked sensitive data thanks to misconfigured Box accounts

    The discoveries were made by Adversis, a cybersecurity firm, which found majortech companies and corporate giants had left data inadvertently exposed

  • Thomson Reuters StreetEvents3 months ago

    Edited Transcript of HLF earnings conference call or presentation 19-Feb-19 10:30pm GMT

    Q4 2018 Herbalife Nutrition Ltd Earnings Call

  • Earnings Signify the End of the Rally in Herbalife Stock
    InvestorPlace4 months ago

    Earnings Signify the End of the Rally in Herbalife Stock

    Herbalife Nutrition (NYSE:HLF) has won its long-running battle with the shorts. Herbalife stock is up 60% since the beginning of 2018, touching an all-time high earlier this month. And most shorts have moved on in the process: less than 10% of HLF stock is sold short at the moment, down from levels that were consistently above 25% as recently as 2017.Source: Shutterstock But Herbalife stock is pulling back slightly in trading on Wednesday. HLF is down 2.6% as of this writing after its fourth-quarter earnings report on Tuesday afternoon. The pullback makes some sense. * 7 Healthy Dividend Stocks to Buy for Extra Stability HLF has put many of its risks behind it. It continues to grow earnings. But 2019 guidance isn't quite as good as investors were hoping for -- and with the stock not far off its highs, more was priced in.InvestorPlace - Stock Market News, Stock Advice & Trading Tips Herbalife EarningsQ4 earnings from Herbalife appear relatively in line with overall expectations. Adjusted earnings per share of 63 cents did decline 3% year over year, but the figure came in 2 cents above analyst expectations. Revenue growth of 9% matched the Street consensus, though an early January update from Herbalife had pointed analysts in the right direction.So, there wasn't much in the way of surprise -- and likely little to change the minds of either bulls or bears. HLF bulls can point to strong performance in both Q4 and for the full year, over which time sales rose 10%. A 30% rise in "volume points" in Asia Pacific during the fourth quarter shows continued improvement in that key Herbalife market.With regulatory pressure in the U.S. seemingly behind the company, that growth is what matters to Herbalife stock. And the company is delivering.The one piece of somewhat disappointing news came in terms of 2019 guidance. Herbalife projects EPS of $2.90-$3.10 for 2019. That's below analyst consensus of $3.20. Currency headwinds may be a factor, however: HLF is guiding for a 22-cent impact on this year's earnings from the stronger dollar. Including that impact, the midpoint of adjusted EPS guidance suggests less than 1% growth. Backing out those external effects, however, Herbalife earnings (on a non-GAAP basis) should rise more than 8% year over year. The HLF Stock Battleground Remains IntactAgain, Q4 results and 2019 guidance likely do little to change the mind of investors on either side of the HLF trade. Bulls see continued growth on both the top and bottom line. The smaller, but still-vocal, bearish contingent will point out, as Josh Enomoto did, that the company still is a multi-level marketer (MLM).Yes, Herbalife settled with U.S. regulators. But foreign entities may have different standards -- a potential risk as Herbalife increasingly focuses as international growth. The stronger dollar makes the potential profit for that risk even smaller, at least for U.S. shareholders.Even the sudden departure of the company's then-CEO last month can be viewed in different ways. It turned out that Richard Goudis was caught on tape telling an employee in Asia to ignore expense-account limits on entertainment. To bears, this was a sign that the company's culture, even at the top, was based on skirting the rules.Yet, Herbalife stock actually touched its all-time high a few weeks after Goudis' departure, likely in part because traders thought the exit opened up the possibility of a go-private deal. Here, too, both sides viewed the news through their own respective lens. Herbalife Stock Isn't CheapFrom here, the HLF battleground looks likely to result in a stalemate after the Q4 report. Bears aren't going anywhere. Neither are bulls. And the valuation assigned to Herbalife stock looks about right -- if not a touch high.The midpoint of 2019 EPS guidance suggests an 18.8 P/E multiple for HLF. That's a multiple that assumes some growth -- and about what Herbalife is projecting it will post in 2019. From that standpoint, HLF looks reasonably valued.But there are risks underlying the story here -- even if bears have overestimated those risks in the past. Note that other MLMs like Nu Skin Enterprises (NYSE:NUS) and Medifast (NYSE:MED) have taken big hits in recent months. (Medifast admittedly had soared before pulling back by roughly 50%; that stock still is up 89% over the past year.)In that context, unless HLF's growth expectations rise over the course of the year, it's tough to see Herbalife stock clearing $60 again. 20 times $3 per share in earnings looks like a potential ceiling -- and suggests just 6.7% returns from this level. * 7 Restaurant Stocks to Watch in 2019 And it's worth remembering that for the first half of the decade, HLF was a volatile stock -- but one that traded mostly sideways. Right now, I'd expect that type of trading to return in 2019 (although, perhaps, in a tighter range given the lower short interest). Q4 results were good, and Herbalife is going to grow. But that's already priced in. For the next few quarters at least, the movement in HLF is going to come down to whether the company can beat guidance -- and whether the bulls can hold off the bears.As of this writing, Vince Martin has no positions in any securities mentioned. More From InvestorPlace * 2 Toxic Pot Stocks You Should Avoid * The 10 Best Cheap Stocks to Buy Right Now * 5 Stocks Under $5 to Buy Before They Soar * 5 Consumer Stocks to Cash Out Of Compare Brokers The post Earnings Signify the End of the Rally in Herbalife Stock appeared first on InvestorPlace.